Skip to main navigation
  • News
  • Contact
Galera Therapeutics, Inc. logo
  • Company
    • About
    • Our Team
    • Board of Directors
  • Science
    • Our Science
    • Radiotherapy-Induced Toxicity
    • Radiotherapy Anti-Cancer Efficacy
    • Scientific Publications
  • Pipeline
    • Our Pipeline
    • Clinical Trials
  • Patients & Caregivers
  • Investors
    • IR Home
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Shareholder Services
  • Careers
  • Contact
Galera Therapeutics, Inc. Investor Relations header background image

SEC Filing Details

Document Details

Form
SCHEDULE 13D
Filing Date
Jun 11, 2026
Document Date
Jun 11, 2026
Form Description
SCHEDULE 13D - Description
Filing Group
Other
Company
Galera Therapeutics, Inc.
Issuer
Galera Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • IR Home
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • SEC Filings
  • Shareholder Services
Galera Therapeutics, Inc. logo

Galera Therapeutics, Inc.

45 Liberty Blvd, Suite 230
Malvern, PA 19355

610-725-1500

info@galeratx.com

Visit us on Twitter Visit us on LinkedIn

©2026 Galera Therapeutics, Inc. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • Expanded Access Policy